Financhill
Back

Actinium Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27

ATNM
Actinium Pharmaceuticals, Inc.

Last Price:
$1.11
Seasonality Move:
11.36%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Actinium Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.11 Buy
20-day SMA: 1.18 Sell
50-day SMA: 1.34 Sell
200-day SMA: 1.51 Sell
8-day EMA: 1.11 Buy
20-day EMA: 1.17 Sell
50-day EMA: 1.28 Sell
200-day EMA: 1.56 Sell

Actinium Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 38.27 Sell
Chaikin Money Flow: 56890 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.12 - 1.3) Sell
Bollinger Bands (100): (1.25 - 1.55) Sell

Actinium Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Actinium Pharmaceuticals, Inc. Stock

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

ATNM Technical Analysis vs Fundamental Analysis

Sell
27
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Is Actinium Pharmaceuticals, Inc. a Buy or a Sell?

Actinium Pharmaceuticals, Inc. Stock Info

Market Cap:
34.6M
Price in USD:
1.11
Share Volume:
75.9K

Actinium Pharmaceuticals, Inc. 52-Week Range

52-Week High:
2.41
52-Week Low:
1.02
Sell
27
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Actinium Pharmaceuticals, Inc. Share Price Forecast

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Actinium Pharmaceuticals, Inc.

Is Actinium Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.20 per share.

Technical Analysis of Actinium Pharmaceuticals, Inc.

Should I short Actinium Pharmaceuticals, Inc. stock?

* Actinium Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.